Aartipharm 543748 full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Aartipharm 543748 WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI BSE stock exchange
Daily price and charts and targets Aartipharm
Strong Daily Stock price targets for Aartipharm 543748 are 841.28 and 869.63
| Daily Target 1 | 819.17 |
| Daily Target 2 | 835.03 |
| Daily Target 3 | 847.51666666667 |
| Daily Target 4 | 863.38 |
| Daily Target 5 | 875.87 |
Daily price and volume Aartipharm
| Date | Closing | Open | Range | Volume | Fri 31 October 2025 | 850.90 (1.95%) | 834.65 | 831.65 - 860.00 | 1.6116 times | Thu 30 October 2025 | 834.65 (0.28%) | 831.10 | 828.00 - 839.95 | 1.1343 times | Wed 29 October 2025 | 832.35 (-1.33%) | 834.05 | 830.55 - 847.20 | 1.4992 times | Tue 28 October 2025 | 843.55 (1.57%) | 831.70 | 829.55 - 846.15 | 0.5655 times | Mon 27 October 2025 | 830.50 (-0.92%) | 842.35 | 830.00 - 842.35 | 0.2488 times | Thu 23 October 2025 | 838.20 (-1.2%) | 874.75 | 834.55 - 874.75 | 1.4429 times | Tue 21 October 2025 | 848.35 (0.71%) | 844.30 | 840.40 - 862.00 | 0.8557 times | Mon 20 October 2025 | 842.40 (1.21%) | 834.15 | 825.05 - 844.30 | 0.6591 times | Fri 17 October 2025 | 832.35 (-2.72%) | 851.40 | 827.10 - 852.25 | 0.6274 times | Thu 16 October 2025 | 855.65 (2.28%) | 836.55 | 832.85 - 857.95 | 1.3555 times | Wed 15 October 2025 | 836.55 (1.04%) | 823.55 | 823.55 - 844.95 | 0.8753 times |
Weekly price and charts Aartipharm
Strong weekly Stock price targets for Aartipharm 543748 are 839.45 and 871.45
| Weekly Target 1 | 814.3 |
| Weekly Target 2 | 832.6 |
| Weekly Target 3 | 846.3 |
| Weekly Target 4 | 864.6 |
| Weekly Target 5 | 878.3 |
Weekly price and volumes for Aartipharm
| Date | Closing | Open | Range | Volume | Fri 31 October 2025 | 850.90 (1.52%) | 842.35 | 828.00 - 860.00 | 0.5472 times | Thu 23 October 2025 | 838.20 (0.7%) | 834.15 | 825.05 - 874.75 | 0.3199 times | Fri 17 October 2025 | 832.35 (-0.02%) | 827.20 | 820.40 - 857.95 | 0.5822 times | Fri 10 October 2025 | 832.55 (0.52%) | 825.55 | 817.25 - 854.65 | 0.9175 times | Fri 03 October 2025 | 828.25 (0.7%) | 838.75 | 803.90 - 838.90 | 0.6984 times | Fri 26 September 2025 | 822.50 (-11.59%) | 921.05 | 819.55 - 924.70 | 1.2218 times | Fri 19 September 2025 | 930.30 (0.4%) | 934.65 | 893.80 - 946.45 | 2.2566 times | Fri 12 September 2025 | 926.55 (4.87%) | 890.00 | 874.70 - 927.80 | 1.2359 times | Fri 05 September 2025 | 883.55 (5.18%) | 840.25 | 826.85 - 896.70 | 0.9338 times | Fri 29 August 2025 | 840.05 (-2.69%) | 868.55 | 812.45 - 868.55 | 1.2867 times | Fri 22 August 2025 | 863.30 (14.02%) | 757.30 | 752.85 - 877.70 | 2.125 times |
Monthly price and charts Aartipharm
Strong monthly Stock price targets for Aartipharm 543748 are 834.08 and 891.58
| Monthly Target 1 | 790.13 |
| Monthly Target 2 | 820.52 |
| Monthly Target 3 | 847.63333333333 |
| Monthly Target 4 | 878.02 |
| Monthly Target 5 | 905.13 |
Monthly price and volumes Aartipharm
| Date | Closing | Open | Range | Volume | Fri 31 October 2025 | 850.90 (2.7%) | 828.65 | 817.25 - 874.75 | 0.3451 times | Tue 30 September 2025 | 828.55 (-1.37%) | 840.25 | 803.90 - 946.45 | 0.7567 times | Fri 29 August 2025 | 840.05 (-7.91%) | 920.80 | 740.60 - 920.80 | 0.8945 times | Thu 31 July 2025 | 912.20 (2.25%) | 902.95 | 884.90 - 971.50 | 0.6168 times | Mon 30 June 2025 | 892.15 (-2%) | 922.85 | 837.90 - 948.80 | 0.6371 times | Fri 30 May 2025 | 910.35 (27.61%) | 712.50 | 682.55 - 917.75 | 1.2407 times | Wed 30 April 2025 | 713.40 (-4.7%) | 758.00 | 594.25 - 806.95 | 0.8657 times | Fri 28 March 2025 | 748.55 (1.98%) | 726.80 | 685.10 - 793.50 | 1.0848 times | Fri 28 February 2025 | 734.05 (25.49%) | 590.85 | 574.00 - 837.00 | 2.3513 times | Fri 31 January 2025 | 584.95 (-14.85%) | 687.00 | 572.00 - 719.50 | 1.2073 times | Tue 31 December 2024 | 687.00 (8.35%) | 624.95 | 550.25 - 714.25 | 1.912 times |
Indicator Analysis of Aartipharm
Tomorrow's movement Prediction of Aartipharm 543748 appears to be in downtrend.
And this trend seems to be continuing further.Price is above an important level of 839.81 on charts, and as long as price remains above this level, the uptrend of stock might continue.
Tomorrow's movement Prediction of Aartipharm 543748 appears to be moving in a flat line. Not much is happening in the stock trend.
Tomorrow's movement Prediction of Aartipharm 543748 appears strongly Bullish. This stock started moving upwards as soon as it opened. Generally this happens when there is a positive sentiment following the stock, making it attractive. There's a good chance that this upwards movement will continue tomorrow as well.
Munafa value: 55 as on Fri 31 October 2025
If this Munafa value is near or nearing 100, then this stock might show an upward movement. However, if this value is near or nearing 10, then this stock might very well show a downward movement.
If the Munafa value is near 50, then the stock might show a sideways movement.
SMA20 is at 837 and price is deviating by 9 points
Upper Bollinger band is at 853 and lower is at 820, while middle bands are at 828 and 845
Price is rising
Price is above 20day SMA
Price is in upper range of bands
Price action analysis of Aartipharm (543748) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Aartipharm stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Aartipharm in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Aartipharm Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Aartipharm in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Aartipharm is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 842.22 and Aartipharm 543748 stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Aartipharm 543748 stock. Volume based technical analysis of Aartipharm 543748 stock is negative.
Aartipharm Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Aartipharm 543748
DMA (daily moving average) of Aartipharm 543748
| DMA period | DMA value |
| 5 day DMA | 838.39 |
| 12 day DMA | 839.45 |
| 20 day DMA | 836.06 |
| 35 day DMA | 857.04 |
| 50 day DMA | 858.01 |
| 100 day DMA | 875.65 |
| 150 day DMA | 843.28 |
| 200 day DMA | 805.73 |
EMA (exponential moving average) of Aartipharm 543748
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 841.15 | 836.27 | 837.08 |
| 12 day EMA | 839.81 | 837.8 | 838.37 |
| 20 day EMA | 841.62 | 840.64 | 841.27 |
| 35 day EMA | 845.59 | 845.28 | 845.91 |
| 50 day EMA | 852 | 852.05 | 852.76 |
SMA (simple moving average) of Aartipharm 543748
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 838.39 | 835.85 | 838.59 |
| 12 day SMA | 839.45 | 837.25 | 837.07 |
| 20 day SMA | 836.06 | 834.94 | 833.64 |
| 35 day SMA | 857.04 | 858.59 | 859.92 |
| 50 day SMA | 858.01 | 856.59 | 855.04 |
| 100 day SMA | 875.65 | 876.39 | 877.36 |
| 150 day SMA | 843.28 | 842.54 | 841.85 |
| 200 day SMA | 805.73 | 804.98 | 804.24 |
Terms of Use Stock Market News! © munafasutra.org2025 All Rights reserved.